Results 111 to 120 of about 15,560 (165)

3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale x‐ray phase‐contrast tomography

Brain Pathology, EarlyView.
x‐ray phase‐contrast tomography enabled three‐dimensional, label‐free visualization and quantification of protein aggregates in neurodegenerative diseases with isotropic submicrometer resolution. The study revealed distinct electron density patterns in Lewy bodies, Hirano bodies, granulovacuolar degeneration, and amyloid plaques, highlighting their ...
Jonas Franz, Jakob Reichmann, Marina Eckermann, Thea Würfel, Artur Groh, Syed Fatima Qadri, Katja Schulz, Brit Mollenhauer, Christine Stadelmann, Tim Salditt   +9 more
wiley   +1 more source

Reversible drug-induced progressive supranuclear palsy-like presentation: A report of three cases

Annals of Movement Disorders, 2019
Drugs, such as dopamine receptor blockers or dopamine depleters, produce a functional dopamine-deficient state mimicking parkinsonism, but presentation with a progressive supranuclear palsy (PSP) is a rare manifestation.
Shivani Rath, Deepika Joshi
doaj   +1 more source

Adult lifespan normative data (18–92 years) for executive function tests; the Stroop colour word test, COWAT and Hayling sentence completion test

Journal of Neuropsychology, EarlyView.
Abstract The neuropsychological assessment of executive functions is an important part of the diagnostic process for many neurological diseases and for predicting the ability of neurological patients to function independently. Unfortunately, for the majority of commonly used executive function tests there is a paucity of updated normative data ...
Patrick Murphy, Emily Webster, Lisa Cipolotti   +2 more
wiley   +1 more source

Progressive Supranuclear Palsy Syndrome: An Overview

IBRO Neuroscience Reports
Progressive supranuclear palsy (PSP) is a neurodegenerative disease, commonly observed as a movement disorder in the group of parkinsonian diseases. The term PSP usually refers to PSP-Richardson’s syndrome (PSP-RS), the most typical clinical presentation.
Eduardo Ichikawa-Escamilla, Rodrigo A. Velasco-Martínez, Laura Adalid-Peralta   +2 more
doaj   +1 more source

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment Design and Cohort Baseline Characteristics of the German Dementia Competence Network [PDF]

, 2009
Background: The German Dementia Competence Network (DCN) has established procedures for standardized multicenter acquisition of clinical, biological and imaging data, for centralized data management, and for the evaluation of new treatments.
Frölich, Lutz, Gertz, Hermann-Josef, Hampel, Harald, Henn, Fritz, Heuser, Isabella, Huell, Michael, Jahn, Holger, Jessen, Frank, Kornhuber, Johannes, Luckhaus, Christian, Maier, Wolfgang, Pantel, Johannes, Perneczky, Robert, Peters, Oliver, Rienhoff, Otto, Ruüther, Eckart, Schmidtke, Klaus, Schroeder, Johannes, Seuchter, Susanne A., Weih, Markus, Wiltfang, Jens, Wolf, Stefanie   +21 more
core   +1 more source

Medicaid expansion and diagnosis experiences of people with frontotemporal dementia

Alzheimer's &Dementia: Behavior &Socioeconomics of Aging, Volume 1, Issue 4, December 2025.
Abstract INTRODUCTION Timely and accurate diagnosis of frontotemporal dementia (FTD) is essential for improving patient quality of life and alleviating caregiver burden. However, individuals with FTD often face barriers to care due to limited insurance coverage.
Catherine E. A. Scipion, Karen E. Nielsen, Margaret A. Manchester, Jalayne J. Arias   +3 more
wiley   +1 more source

Research on progressive supranuclear palsy

Chinese Journal of Contemporary Neurology and Neurosurgery, 2011
DOI：10.3969/j.issn.1672-6731.2011.01 ...
Yiming LIU, Jiazhen LI
doaj  

Association between higher cerebrospinal fluid levels of phosphorylated tau and reduced depressive symptoms in patients with cognitive decline

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim In individuals with cognitive decline, depressive symptoms can affect disease progression and quality of life. One factor that may be associated with depressive symptoms is phosphorylated tau (p‐tau). However, the association between p‐tau and depressive symptoms remains controversial.
Takashi Ozaki, Naoki Hashimoto, Hisashi Narita, Niki Udo, Shizuka Mito, Shin Nakagawa, Ichiro Kusumi, Takahiro A. Kato   +7 more
wiley   +1 more source

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders. [PDF]

, 2019
Purpose of reviewThe aim of this study was to examine the synaptic biomarker neurogranin in cerebrospinal fluid (CSF) in different stages of HIV infection and in relation to what is known about CSF neurogranin in other neurodegenerative diseases.Recent ...
Blennow, Kaj, Fuchs, Dietmar, Gisslén, Magnus, Price, Richard W, Spudich, Serena, Yilmaz, Aylin, Zetterberg, Henrik   +6 more
core   +1 more source

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation [PDF]

, 2018
Sporadic cases account for 90-95% of all patients with Parkinson's Disease (PD). Atypical Parkinsonism comprises approximately 20% of all patients with parkinsonism.
Abramov, AY, Angelova, PR, Barilani, M, Dossena, M, Gandhi, S, Lazzari, L, Lovejoy, C, Pezzoli, G, Piga, D, Seresini, A, Viganò, M   +10 more
core   +2 more sources